Advances in lipid management: empowering pharmacists to lower LDL-C to target
This promotional webinar has been developed and funded by Novartis Pharmaceuticals UK Ltd and jointly organised with the PCPA. It is intended for UK healthcare professionals only.
Advances in lipid management: empowering pharmacists to lower LDL-C to target
10th July 8pm - 9pm
Three key takeaways
- Urgency to Treat: educate on the importance of lowering LDL-C to target in secondary prevention of ASCVD
- Lipid Management Guidelines: explain the ESC guidelines and changes to QOF 2025/26
- Optimal Treatment sequencing of ASCVD patients: discuss treatment options to lower LDL-C and importance of treatment sequencing
Speaker

Prof. Raj Thakkar
GP Professor and President of Primary Care Cardiovascular Society
Prof. Raj trained at UCL and in the Oxford Deanery. His varied roles include working as a GP partner since 2004, primary care cardiology lead for the Oxford Health Innovation Network and national primary care workstream co-lead for the cardiac transformation programme (NHSE). He is also on the national expert advisory groups for lipids, heart attack and heart failure. Raj is the President of the Primary Care Cardiovascular Society, Honorary Visiting Professor at Cardiff University Medical School and works in industry. Previous roles have included Clinical Commissioning Director for Bucks CCG/BOB ICB in planned care, Cardiac Lead for the Thames Valley Strategic Clinical Network, and atrial fibrillation champion for NHSIQ Thames Valley
Raj has worked as a presenter on BBC Radio and is a medical writer, speaker, and advisor. He has written and published over 200 articles and several books including the MIMS consultation guide which won the BMA book of the year award in the category of medicine. He has achieved two atrial fibrillation pioneer awards, was a national finalist for GP of the year in 2017 and a national HSJ finalist -2019 for his work in atrial fibrillation.
Chair: Helen Kilminster
PCPA National Vice President & Senior Clinical Pharmacist
FA-11421692 | May 2025